HOUSTON, TX, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced publication of a landmark study titled, “Altered ...
Hosted on MSN
'Landmark' £1.5bn sale of university company
A company that makes devices that keep organs alive outside of the human body has been acquired by a global medical technology company in a "landmark" deal. OrganOx, a spinout of the University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback